BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1633912)

  • 1. Massive ascites after leuprolide acetate administration for the treatment of leiomyomata uteri.
    Lee MJ; Kazer RR
    Fertil Steril; 1992 Aug; 58(2):416-8. PubMed ID: 1633912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS
    Fertil Steril; 1992 Aug; 58(2):413-5. PubMed ID: 1633911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrated ascites re-infusion therapy for pseudo-Meigs' syndrome complicated by massive ascites in large pedunculated uterine leiomyoma.
    Yonehara Y; Yanazume S; Kamio M; Togami S; Tasaki T; Douchi T
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1944-9. PubMed ID: 25056475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of leuprolide acetate treatment on histopathology of uterine myomata.
    Gutmann JN; Thornton KL; Diamond MP; Carcangiu ML
    Fertil Steril; 1994 Apr; 61(4):622-6. PubMed ID: 8150102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of leuprolide acetate on treatment of leiomyomata--clues to mechanisms of action.
    Demopoulos RI; Mesia AF
    Adv Anat Pathol; 1998 Mar; 5(2):129-36. PubMed ID: 9868519
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute urinary retention after gonadotropin-releasing hormone agonist treatment for leiomyomata uteri.
    Friedman AJ
    Fertil Steril; 1993 Mar; 59(3):677-8. PubMed ID: 8458477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of two different doses of leuprolide acetate depot on uterine cavity area in patients with uterine leiomyomata.
    Watanabe Y; Nakamura G
    Fertil Steril; 1995 Mar; 63(3):487-90. PubMed ID: 7851574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women.
    Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H
    Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of leuprorelin acetate depot in symptomatic fibromatous uteri: the Italian Multicentre Trial.
    Serra GB; Panetta V; Colosimo M; Romanini C; Lafuenti GB; Garcea N; Votano S; Agatensi L
    Clin Ther; 1992; 14 Suppl A():57-73. PubMed ID: 1606594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.
    Friedman AJ; Daly M; Juneau-Norcross M; Gleason R; Rein MS; LeBoff M
    Hum Reprod; 1994 Sep; 9(9):1618-25. PubMed ID: 7836510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri.
    Scialli AR; Jestila KJ
    Fertil Steril; 1995 Aug; 64(2):313-20. PubMed ID: 7615109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Size reduction of uterine myomas with monthly administered leuprolide acetate].
    Cheviakoff S; Bocaz JA; Martínez L; Romero C
    Rev Chil Obstet Ginecol; 1994; 59(6):416-20; discussion 420-1. PubMed ID: 7569160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy.
    Friedman AJ; Rein MS; Harrison-Atlas D; Garfield JM; Doubilet PM
    Fertil Steril; 1989 Nov; 52(5):728-33. PubMed ID: 2509250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri.
    Scialli AR; Levi AJ
    Fertil Steril; 2000 Sep; 74(3):540-6. PubMed ID: 10973652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology of leiomyomata in patients treated with leuprolide acetate.
    Demopoulos RI; Jones KY; Mittal KR; Vamvakas EC
    Int J Gynecol Pathol; 1997 Apr; 16(2):131-7. PubMed ID: 9100066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meigs' syndrome and pseudo-Meigs' syndrome.
    O'Flanagan SJ; Tighe BF; Egan TJ; Delaney PV
    J R Soc Med; 1987 Apr; 80(4):252-3. PubMed ID: 3585894
    [No Abstract]   [Full Text] [Related]  

  • 18. Aborted leiomyosarcoma after treatment with leuprolide acetate.
    Mesia AF; Williams FS; Yan Z; Mittal K
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):664-6. PubMed ID: 9764655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: a pilot study.
    Friedman AJ
    Fertil Steril; 1989 Mar; 51(3):526-8. PubMed ID: 2537769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of vascular changes in leuprolide acetate-treated leiomyomas.
    Mesia AF; Gahr D; Wild M; Mittal K; Demopoulos RI
    Am J Obstet Gynecol; 1997 May; 176(5):1026-9. PubMed ID: 9166163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.